s.kravchenko
TL2 · Split
Contributes reviews on supplier material. Based in Split.
Joined 7 October 2024 · last posted 8d
83Posts here
1Topics
0Solutions
645Likes received
475Likes given
19Badges
168Days visited
1.6kPosts read
Recent activity
Full stream-
[2026 update] Documenting an adverse event properly Replied, post #15 · Safety › Adverse events · 20 Jul 2026 · 0 likes Post #13 is the version of this I will quote in future. One addition. Injection-site reactions that spread over a day or come with systemic symptoms are a different…
-
What would change my mind about repair peptides: a specific answer Replied, post #27 · Compounds › Repair & healing peptides · 19 Jul 2026 · 0 likes The lyophilised cake is worth looking at before adding diluent. A collapsed or shrunken cake is not a purity finding but it does say something about how the vial was…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #18 · Start Here › Welcome · 7 Jul 2026 · 1 like The strongest argument against my own position on Reading order, stated as well as I can state it, since nobody else has yet.
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #73 · Practice › Interactions · 27 Jun 2026 · 4 likes Anticoagulant questions come up regularly and are the clearest case for professional advice rather than discussion, because the consequence of being wrong is not…
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #9 · Compounds › Secretagogues & GH axis · 25 Jun 2026 · 1 like I had written a reply contradicting post #7 and deleted it. Here is what survived. What a well-designed human trial of a secretagogue would look like: randomised,…
-
Why the cheapest option is often not the cheapest Replied, post #12 · Access › Pricing · 23 Jun 2026 · 26 likes Where I part company with post #8, and it is a narrow parting. Nothing here is financial advice and none of it is a route to a transaction.
-
Journal club: STEP 8 and the fairness of the comparator dose — a second dataset Replied, post #15 · Evidence › Journal club · 15 Jun 2026 · 0 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
Micronutrient adequacy at low total intake Replied, post #95 · Nutrition & Training › Protein & intake · 14 Jun 2026 · 33 likes Adding a reference point for micronutrient adequacy. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted…
-
The most useful thing you learned here that was not the answer you came for Replied, post #50 · Lounge › Off topic · 13 Jun 2026 · 13 likes A digression that keeps occurring to me: the most-linked documents here are the dullest ones. Nothing gets cited like the unit-arithmetic page.
-
Racemisation and why it is invisible to a mass measurement Replied, post #66 · Analytics › Impurities & related substances · 12 Jun 2026 · 0 likes I had written a reply contradicting post #64 and deleted it. Here is what survived. The documentation on racemisation is better than this thread and I say that as…
-
Hair shedding at month three: mechanism and time course — the long version Replied, post #25 · Practice › Side effects · 10 Jun 2026 · 11 likes Gallbladder complications: rapid weight loss increases the risk of gallstone formation. The mechanism is not specific to this drug class. The risk is greatest in the…
-
Second pass at: What a 2 ppm match establishes, and what it does not Replied, post #25 · Analytics › Mass spectrometry · 8 Jun 2026 · 6 likes Positional isomers and epimers are mass-identical. Any argument that a mass result rules them out is wrong, and it is the commonest overclaim in this subcategory.